𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Opportunistic infections after liver transplantation in patients infected with human immunodeficiency virus

✍ Scribed by Elina Teicher; Jean-Charles Duclos-Vallée

Publisher
John Wiley and Sons
Year
2012
Tongue
English
Weight
695 KB
Volume
18
Category
Article
ISSN
1527-6465

No coin nor oath required. For personal study only.

✦ Synopsis

Spanish Foundation for the Investigation and Prevention of Acquired Immunodeficiency Syndrome/Spanish Group for the Study of Acquired Immunodeficiency Syndrome Prospective Cohort Study.'' 1 Surprisingly, in a cohort of 84 consecutive patients coinfected with human immunodeficiency virus (HIV) and hepatitis C virus who underwent liver transplan

📜 SIMILAR VOLUMES

Hepatitis E virus infection in patients
Hepatitis E virus infection in patients infected with the human immunodeficiency virus
✍ Mamadou Kaba; Hervé Richet; Isabelle Ravaux; Jacques Moreau; Isabelle Poizot-Mar 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 212 KB 👁 1 views

## Abstract Hepatitis E virus (HEV) is a newly‐identified causative agent of acute and chronic hepatitis in severely immunocompromized patients. The present study sought to assess the prevalences of past, recent, on‐going, and chronic HEV infections in patients infected with human immunodeficiency

Outcome of patients with hepatitis B vir
Outcome of patients with hepatitis B virus and human immunodeficiency virus infections referred for liver transplantation
✍ Norah A. Terrault; Jonathan T. Carter; Laurie Carlson; Michelle E. Roland; Peter 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB 👁 2 views

The outcome of patients with hepatitis B virus (HBV) and human immunodeficiency virus (HIV) referred for liver transplantation (LT) is unknown. A high frequency of lamivudine-resistant (LAM-R) HBV infection may increase the risk of liver-related death pre-transplantation and prophylaxis failure post

Liver transplantation in human immunodef
Liver transplantation in human immunodeficiency virus–infected patients: Procoagulant, but is antithrombotic prophylaxis required?
✍ P. Thomas Cherian; Wesal Alrabih; Abdel Douiri; Alberto Quaglia; Michael A. Hene 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

Liver transplantation (LT) for human immunodeficiency virus (HIV)-positive recipients with end-stage liver disease has become an accepted practice. However, because these patients are increasingly being recognized as prothrombotic, we reviewed their posttransplant thrombotic complications. Because m

Enfuvirtide: A safe and effective antire
Enfuvirtide: A safe and effective antiretroviral agent for human immunodeficiency virus–infected patients shortly after liver transplantation
✍ Elina Teicher; Chadi Abbara; Jean-Charles Duclos-Vallée; Teresa Antonini; Lauren 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB

The aim of this study was to evaluate the impact of an enfuvirtide-based antiretroviral (ARV) regimen on the management of immunosuppression and follow-up in hepatitis C virus (HCV)/hepatitis B virus (HBV)/human immunodeficiency virus (HIV)-coinfected liver transplant patients in comparison with a l

A new indication for liver transplantati
A new indication for liver transplantation: Nodular regenerative hyperplasia in human immunodeficiency virus–infected patients
✍ Mariagrazia Tateo; Mylène Sebagh; Marie-Pierre Bralet; Elina Teicher; Daniel Azo 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 219 KB

Nodular regenerative hyperplasia is one of the causes of noncirrhotic portal hypertension and has recently been described in human immunodeficiency virus-infected patients, and the potential role of a prothrombotic state and hepatotoxic antiretroviral medication has been suggested. Moreover, it is n